Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Chang

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Journal of Neuro-Oncology|July 9, 2011
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment deliveryMark R Gilbert, John Kuhn, Kathleen R Lamborn, et al.
Public Health Reports (Washington, D.C. : 1974)|April 21, 2020
Polydrug Use During Pregnancy and Preterm Birth in a Low-Income, Multiethnic Birth Cohort, Boston, 1998-2018Henri M Garrison-Desany, Nobutoshi Nawa, Yoona Kim, et al.
Nature Cancer|December 20, 2022
A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targetsLin Wang, Jangham Jung, Husam Babikir, et al.
Neuro-Oncology|January 31, 2006
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant gliomaMichael D Prados, Kathleen R Lamborn, Susan Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2007
Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiformeAllen M Chen, Susan Chang, Jean Pouliot, et al.
International Journal of Cancer|May 2, 2009
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide eraJoseph L Wiemels, David Wilson, Chirag Patil, et al.
Magnetic Resonance Imaging|December 6, 2006
Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 TYan Li, Joseph A Osorio, Esin Ozturk-Isik, et al.
Journal of Neurosurgery|September 10, 2003
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes ProjectEdward R Laws, Ian F Parney, Wei Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2002
Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant gliomaDavid A Larson, Michael Prados, Kathleen R Lamborn, et al.
Neuro-Oncology Practice|April 26, 2021
Cognitive impact of lower-grade gliomas and strategies for rehabilitationChristina Weyer-Jamora, Melissa S Brie, Tracy L Luks, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Journal of Neuro-Oncology|July 9, 2011
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment deliveryMark R Gilbert, John Kuhn, Kathleen R Lamborn, et al.
Public Health Reports (Washington, D.C. : 1974)|April 21, 2020
Polydrug Use During Pregnancy and Preterm Birth in a Low-Income, Multiethnic Birth Cohort, Boston, 1998-2018Henri M Garrison-Desany, Nobutoshi Nawa, Yoona Kim, et al.
Nature Cancer|December 20, 2022
A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targetsLin Wang, Jangham Jung, Husam Babikir, et al.
Neuro-Oncology|January 31, 2006
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant gliomaMichael D Prados, Kathleen R Lamborn, Susan Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2007
Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiformeAllen M Chen, Susan Chang, Jean Pouliot, et al.
International Journal of Cancer|May 2, 2009
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide eraJoseph L Wiemels, David Wilson, Chirag Patil, et al.
Magnetic Resonance Imaging|December 6, 2006
Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 TYan Li, Joseph A Osorio, Esin Ozturk-Isik, et al.
Journal of Neurosurgery|September 10, 2003
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes ProjectEdward R Laws, Ian F Parney, Wei Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2002
Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant gliomaDavid A Larson, Michael Prados, Kathleen R Lamborn, et al.
Neuro-Oncology Practice|April 26, 2021
Cognitive impact of lower-grade gliomas and strategies for rehabilitationChristina Weyer-Jamora, Melissa S Brie, Tracy L Luks, et al.
Pageof 12